Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia

References

• Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
   PubMed Web of Science ®Google Scholar
• Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198–206.
   PubMed Web of Science ®Google Scholar
• Matutes E, Oscier D, Garcia-Marco J, et al. Trissomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996;92:382–388.
   PubMed Web of Science ®Google Scholar
• Schwarz J, Mikulenkova D, Cermakova K, et al. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVh gene mutational status and other prognostic markers. Neoplasma 2006;53:219–225.
   PubMed Web of Science ®Google Scholar
• Hallek M, Wanders L, Ostwald M, et al. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma 1996;22:439–447.
   PubMed Web of Science ®Google Scholar
• Wierda WG, O'Brien S, Wang X, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 2007;109:4679–4685.
   PubMed Web of Science ®Google Scholar
• Rozman C, Montserrat E, Rodríguez-Fernández JM, et al. Bone marrow histologic pattern: the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984;64:642–648.
   PubMed Web of Science ®Google Scholar
• Damle RN, Wasil T, Fais F, et al. IgV gene mutational status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840–1847.
   PubMed Web of Science ®Google Scholar
• Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002;99:1023–1029.
   PubMed Web of Science ®Google Scholar
• Domingo-Domènech E, Domingo-Claros A, González-Barca E, et al. CD38 expression in B-cell chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Haematologica 2002;87:1021–1027.
   PubMed Web of Science ®Google Scholar
• Krober A, Seiler T, Benner A, et al. Vh mutational status, CD38 expression level, genomic aberrations and survival in chronic lymphocytic leukemia. Blood 2002;100: 1410–1416.
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin variable region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764–1775.
   PubMed Web of Science ®Google Scholar
• Del Giudice I, Morilla A, Osuji N, et al. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer 2005;104:2124–2132.
   PubMed Web of Science ®Google Scholar
• Schroers R, Griesinger F, Trumper L, et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-chronic lymphocytic leukemia. Leukemia 2005;19:750–758.
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukaemia. N Engl J Med 2000;343:1910–1916.
   PubMed Web of Science ®Google Scholar
• Döhner H, Stilgenbauer S, James MR, et al. 11q deletions identify a new subset of B-chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997;89:2516–2522.
   PubMed Web of Science ®Google Scholar
• Döhner H, Fischer K, Bentz M, et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogues in chronic B-cell lymphocytic leukemia. Blood 1995;85:1580–1589.
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Sander S, Bullinger L, et al. Clonal evolution in chronic lymphocytic leukaemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy and short survival. Haematologica 2007;92:1242–1245.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Witzig TE, Fink SR, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukaemia. J Clin Oncol 2006;24:4634–4641.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennet JM, Grever M, et al. National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
   PubMed Web of Science ®Google Scholar
• Oscier DG, Matutes E, Copplestone A, et al. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 1997;98:934–939.
   PubMed Web of Science ®Google Scholar
• Letestu R, Rawstron A, Ghia P, et al. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukaemia: a multicentric international harmonization process. Cytometry B Clin Cytom 2006;70:309–314.
   PubMed Web of Science ®Google Scholar
• Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640–1645.
   PubMed Web of Science ®Google Scholar
• ISCN. An international system for human cytogenetic nomenclature. BaselS. Karger AG1995.
   Google Scholar
• Hus I, Bojarska-Junak A, Dmoszynska A, et al. ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukemia and combined analysis improves their predictive value. Folia Histochem Cytobiol 2008;46:147–152.
   PubMed Web of Science ®Google Scholar
• Muntañola A, Bosch F, Arguis P, et al. Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia. J Clin Oncol 2007;25:1576–1580.
   PubMed Web of Science ®Google Scholar
• Del Poeta G, Maurillo L, Venditti A, et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001;98:2633–2639.
   PubMed Web of Science ®Google Scholar
• Chevallier P, Penther D, Avet-Loiseau H, et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukemia. Br J Haematol 2002;116:142–150.
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Keating M, Do KA, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98:181–186.
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler T, Dignum H, Taylor PR, et al. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukemia. Br J Haematol 2002;118:755–761.
   PubMed Web of Science ®Google Scholar
• Jelinek DF, Tschumper RC, Geyer SM, et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-cell chronic lymphocytic leukemia. Br J Haematol 2001;115:854–861.
   PubMed Web of Science ®Google Scholar
• Dewald GW, Brockman SR, Pasternoster SF, et al. Chromosome anomalies detected by interphase FISH: correlation with significant biological features of B-cell chronic lymphocytic leukemia. Br J Haematol 2003;121:287–295.
   PubMed Web of Science ®Google Scholar
• Del Principe MI, Del Poeta G, Buccisano F, et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 2006;108:853–861.
   PubMed Web of Science ®Google Scholar